MetaVia Inc. (NASDAQ:MTVA) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of class A Units and Class B Units (common stock or equivalents with Series C and Series D Warrants) Closed: US$9.3M raised · US$3.1 a unit · Warrants at US$3.1 for 60 months · Ladenburg Thalmann & Co. Inc. Dealers: Ladenburg Thalmann & Co. Inc. (lead) Use of proceeds: Working capital and general corporate purposes, including continued clinical development of DA-1726 for obesity | Jan 16, 2026 |
| Private placement of common stock and pre-funded warrants Closed: US$10M raised · US$0.71 a share · Ladenburg Thalmann & Co. Inc. Dealers: Ladenburg Thalmann & Co. Inc. (lead) Use of proceeds: Working capital and corporate purposes, including continued clinical development of DA-1726 for obesity | May 14, 2025 |